Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-125
Closed -$6.26K 1029
2025
Q4
$6.26K Hold
125
﹤0.01% 538
2025
Q3
$6.13K Hold
125
﹤0.01% 549
2025
Q2
$6.47K Hold
125
﹤0.01% 544
2025
Q1
$5.84K Hold
125
﹤0.01% 543
2024
Q4
$6.4K Buy
+125
New +$6.48K ﹤0.01% 524

Other funds holding SNV

Brown, Lisle/Cummings's SNV Position: Q1 2026 in Review

Brown, Lisle/Cummings sold out of Synovus (SNV) in Q1 2026, closing a stake of 125 shares — an estimated $6.26K sold.

Brown, Lisle/Cummings first reported a position in SNV in Q4 2024 and held it in 5 quarters. The position peaked at $6.47K in Q2 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • Brown, Lisle/Cummings reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • Brown, Lisle/Cummings sold 125 Synovus shares in Q1 2026, an estimated $6.26K.
  • Brown, Lisle/Cummings first reported a position in Synovus in Q4 2024 and held it in 5 quarters.
  • Brown, Lisle/Cummings's Synovus position peaked at $6.47K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.